{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:51:43Z","timestamp":1762455103477,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1123274"],"award-info":[{"award-number":["1123274"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012128","name":"Austin Medical Research Foundation","doi-asserted-by":"publisher","award":["1062418","1050765"],"award-info":[{"award-number":["1062418","1050765"]}],"id":[{"id":"10.13039\/100012128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011856","name":"Mauritius Research Council","doi-asserted-by":"publisher","award":["MR\/N022556\/1"],"award-info":[{"award-number":["MR\/N022556\/1"]}],"id":[{"id":"10.13039\/501100011856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ebiom.2018.01.041","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T03:47:19Z","timestamp":1517543239000},"page":"166-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy"],"prefix":"10.1016","volume":"29","author":[{"given":"Roxanne","family":"Hastie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elgene","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Sluka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenore","family":"Ellett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Brownfoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu'uhevaha J.","family":"Kaitu'u-Lino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2018.01.041_bb0005","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.3747\/co.24.3486","article-title":"Efficacy of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status","volume":"24","author":"Bilir","year":"2017","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0010","first-page":"5","article-title":"In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence","volume":"16","author":"Binet","year":"1989","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0015","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/humrep\/17.12.3224","article-title":"Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases","volume":"17","author":"Bouyer","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0020","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1158\/1078-0432.CCR-09-0970","article-title":"Dose-ranging study of metronomic oral Vinorelbine in patients with advanced refractory cancer","volume":"15","author":"Briasoulis","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12885-015-1354-2","article-title":"Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)","volume":"15","author":"Camerini","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0030","first-page":"46","article-title":"Ectopic pregnancy\u2014United States, 1990-1992","volume":"44","author":"Centre for Disease Control and Prevention","year":"1995","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0035","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/ijc.29647","article-title":"Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors","volume":"137","author":"Dal Bello","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2012.06.041","article-title":"Fertility after tubal ectopic pregnancy: results of a population-based study","volume":"98","author":"DE Bennetot","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00000421-199104000-00004","article-title":"A phase II study of navelbine (vinorelbine) in the treatment of non-small-cell lung cancer","volume":"14","author":"Depierre","year":"1991","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0050","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1023\/A:1013567022670","article-title":"Oral vinorelbine: feasibility and safety profile","volume":"12","author":"Depierre","year":"2001","journal-title":"Ann. Oncol."},{"year":"2005","series-title":"Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"Food Drug Administration","key":"10.1016\/j.ebiom.2018.01.041_bb0055"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0060","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.1993.11.7.1245","article-title":"Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy","volume":"11","author":"Fumoleau","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1517\/14740338.4.5.915","article-title":"Oral versus intravenous vinorelbine: clinical safety profile","volume":"4","author":"Gebbia","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1200\/JCO.1988.6.2.270","article-title":"Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors","volume":"6","author":"Gershenson","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0075","first-page":"1907","article-title":"Vinorelbine\u2014a clinical review","volume":"82","author":"Gregory","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1095\/biolreprod.109.077800","article-title":"Models for study of human embryo implantation: choice of cell lines?","volume":"82","author":"Hannan","year":"2010","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0085","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0959-8049(98)00416-X","article-title":"Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts","volume":"35","author":"Hill","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.coc.0000256103.21797.e5","article-title":"Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung carcinoma (NSCLC): a randomized phase II trial","volume":"30","author":"Hirsh","year":"2007","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hon.802","article-title":"Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy","volume":"25","author":"Hodgson","year":"2007","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0100","doi-asserted-by":"crossref","first-page":"d3397","DOI":"10.1136\/bmj.d3397","article-title":"Diagnosis and management of ectopic pregnancy","volume":"342","author":"Jurkovic","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0105","series-title":"Mammalian Cell Viability: Methods and Protocols","first-page":"33","article-title":"The xCELLigence system for real-time and label-free monitoring of cell viability","author":"Ke","year":"2011"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12884-016-0959-z","article-title":"Examining the impact of introducing ICD-MM on observed trends in maternal mortality rates in the UK 2003-13","volume":"16","author":"Knight","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/rep.1.00976","article-title":"Differential glucocorticoid effects on proliferation and invasion of human trophoblast cell lines","volume":"132","author":"Mandl","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0120","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1023\/A:1013180903805","article-title":"Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors","volume":"12","author":"Marty","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn012","article-title":"Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis","volume":"14","author":"Mol","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/AOG.0b013e3182a1ba56","article-title":"Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growth","volume":"122","author":"Nilsson","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0135","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1139\/o90-197","article-title":"The discovery of the vinca alkaloids\u2014chemotherapeutic agents against cancer","volume":"68","author":"Noble","year":"1990","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0140","first-page":"427","article-title":"The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics","volume":"2","author":"Okouneva","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0145","first-page":"115","article-title":"Navelbine: an ultrastructural study of its effects","volume":"32","author":"Paintrand","year":"1983","journal-title":"J. Electron Microsc."},{"year":"2002","series-title":"NAVELBINE (Vinorelbine Tartrate) (Prescribing Information) [Online]","author":"Pierre Fabre M\u00e8dicament Production","key":"10.1016\/j.ebiom.2018.01.041_bb0150"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0155","first-page":"e15","article-title":"Diagnosis and management of ectopic pregnancy: green-top guideline no. 21","volume":"123","author":"RCOG","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0160","first-page":"739","article-title":"Effects of high-dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing postoperative adjuvant treatment of osteosarcoma","volume":"65","author":"Shamberger","year":"1981","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0b013e3182a14cfb","article-title":"Combination gefitinib and methotrexate compared with methotrexate alone to treat ectopic pregnancy","volume":"122","author":"Skubisz","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/humupd\/dmh021","article-title":"Fertility preservation in female patients","volume":"10","author":"Sonmezer","year":"2004","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0175","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00006250-200806000-00044","article-title":"ACOG practice bulletin no. 94: medical management of ectopic pregnancy","volume":"111","author":"The ACOG Task Force","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/molehr\/gau084","article-title":"Molecular diagnostics and therapeutics for ectopic pregnancy","volume":"21","author":"Tong","year":"2015","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00001813-199807000-00007","article-title":"Human ovarian cancer xenografts in nude mice: chemotherapy trials with paclitaxel, cisplatin, vinorelbine and titanocene dichloride","volume":"9","author":"Villena-Heinsen","year":"1998","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ebiom.2018.01.041_bb0190","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s002800050989","article-title":"The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review","volume":"44","author":"Wang","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0195","first-page":"204","article-title":"Reproductive outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia","volume":"59","author":"Wong","year":"2014","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ebiom.2018.01.041_bb0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1471-2407-10-281","article-title":"Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients","volume":"10","author":"Zhou","year":"2010","journal-title":"BMC Cancer"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418300458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418300458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:47:23Z","timestamp":1762454843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418300458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":40,"alternative-id":["S2352396418300458"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.01.041","relation":{},"ISSN":["2352-3964"],"issn-type":[{"type":"print","value":"2352-3964"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}